Clinical and Diagnostic Laboratory Immunology, September 2001, p. 949-954, Vol. 8, No. 5
1071-412X/01/$04.00+0 DOI: 10.1128/CDLI.8.5.949-954.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
9V
2 T Cells in Human Legionellosis
Departments of Infectious Diseases1 and Clinical Bacteriology,4 Umeå University, Umeå University Hospital, SE-901 85 Umeå, and Defense Research Establishment, SE-901 82 Umeå,3 Sweden, and Institute of Radiobiology and Immunology, PMMA, Hradec Kralove, Czech Republic2
Received 26 March 2001/Returned for modification 17 May 2001/Accepted 11 July 2001
| |
ABSTRACT |
|---|
|
|
|---|
In humans, expansion of circulating V
9V
2 T cells seems to be
a pathophysiological denominator shared by protozoan and intracellular bacterial diseases. The assumption was tested here on legionellosis, a
condition conforming to the category but not yet described with respect
to 
T cells. Levels of V
9V
2 T cells in peripheral blood
were measured at various intervals in 14 subjects undergoing a Pontiac
fever-like disease, shown by serological investigation to be caused by
Legionella micdadei. In samples obtained 4 to 6 days
after the onset of the disease, the mean percentage (± the standard
deviation) of V
9V
2+ T cells among CD3+
cells was 1.0% ± 0.5%, compared to 5.0% ± 3.9% in healthy control subjects (P < 0.001). Thereafter, a pronounced
increase occurred and at 2 to 7 weeks after onset, mean peak levels
were as high as
15%. During the next 6 months, values slowly
declined, although without reaching the normal range. Percentages of

+ T cells expressing tumor necrosis factor alpha or
gamma interferon in response to phorbol myristate acetate were assayed
in vitro. At 14 to 16 days after the onset of disease, the expression
of both cytokines was increased (P < 0.01),
whereas at 5 to 7 weeks, the expression of tumor necrosis factor alpha
was decreased (P < 0.05), possibly reflecting
modulation of an inflammatory response. In conclusion, Pontiac fever
was found to be associated with a pronounced and long-lasting expansion
of V
9V
2 T cells, implying that the subset may also be
pathophysiologically important in a mild and transient form of
intracellular bacterial diseases. Surprisingly, the expansion was
preceded by a depletion of circulatory V
9V
2 T cells. Possibly,
V
9V
2 T cells are initially recruited to a site of infection
before they expand in response to antigen and occur in high numbers in blood.
| |
INTRODUCTION |
|---|
|
|
|---|
Legionella is a genus of gram-negative bacteria and the cause of two different clinical entities. One of them is Legionnaires' disease, a severe pneumonic disease associated with a relatively low attack rate, a long incubation period, and a significant mortality rate (8, 9, 39). Pontiac fever, the other entity, is an acute, influenza-like disease with a brief incubation period, a high attack rate, and a self-limiting course (12, 16). Although both cause a high fever, the difference in clinical expression between the two forms of legionellosis is striking. Due to the transient nature of Pontiac fever, it has even been questioned whether this entity is indeed associated with invasive infection and not a host response to dead bacteria, bacterial toxins, or other bacterial products present in an inhaled aerosol (23, 29). In Legionnaires' disease, as well as Pontiac fever, Legionella pneumophila has been the species most frequently identified. In two reported outbreaks of whirlpool-associated Pontiac fever, however, L. micdadei was implicated as the causative agent (17, 27).
Members of the genus Legionella are facultatively
intracellular pathogens, and consequently, the pathogenesis of
legionellosis bears similarity to that of tuberculosis, listeriosis,
brucellosis, tularemia, and Q fever. The host control of all of these
infections depends, to a large extent, on T cells. Like other
facultatively intracellular pathogens, Legionella bacteria
replicate in mononuclear phagocytes, thereby inducing an 
T-cell-dependent, major histocompatibility complex-restricted immune
response to bacterial peptides (20).
Besides 
T cells, 1 to 5% of circulating T cells express the

T-cell receptor (TCR). Increased levels of 
T cells are found in the circulation of patients with protozoan (19, 33, 35) and intracellular bacterial infections, including
mycobacterial disease (21), listeriosis (22),
brucellosis (2), tularemia (32, 37), and Q
fever (36).
Unlike that of 
T cells, the role of 
T cells in
host-parasite interactions is poorly understood. In humans, a sentinel role is ascribed to 
T cells, i.e., a major
histocompatibility complex-independent recognition of broadly
cross-reactive antigens (6). Cells of one single subset of

T cells, V
9V
2 T cells, account for the increased levels in
protozoan and intracellular bacterial diseases. These cells recognize
phosphorylated metabolic intermediates, so-called phosphoantigens,
which are produced by the causative agents (5, 30, 32,
38).
Like 
T cells, 
T cells are endowed with the ability to
produce cytokines. In response to microbial antigens, V
9V
2 T cells produce large amounts of tumor necrosis factor alpha (TNF-
) (25) and gamma interferon (IFN-
) (11, 14).
Although this would indicate a role primarily in the acute phase of
disease, they are also believed to be involved in a later down
regulation of the inflammatory response of macrophages in bacterial and
viral infections (4). A majority of V
9V
2 T cells
express CD94, a member of the type C lectin family of killer inhibitory
receptor molecules. Signaling through CD94 interferes with the
activation of V
9V
2 T cells, suggesting a role of the surface
receptor in the control of V
9V
2 T-cell reactivity
(31).
The 
T-cell response seems not to have been studied in
legionellosis. When faced with an outbreak of Pontiac fever-like disease, we analyzed levels of V
9V
2 T cells in blood. We
investigated whether such a transient and mild condition caused by a
facultatively intracellular bacterium would indeed induce a V
9V
2
T-cell response similar to what had been previously described in more
invasive and severe intracellular infections. In the outbreak,
comprising 14 cases of Pontiac fever-like disease with a short and
well-defined incubation period, we observed an initial decline in
V
9V
2 T cells in peripheral blood, followed by a dramatic increase
and a slow decline over several months, suggesting a dynamic
redistribution and expansion of the subset.
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
Subjects. Fourteen patients (six men, eight women; 22 to 57 [median, 46] years old) were included in the study. After spending a weekend at a hotel and visiting a whirlpool facility at the establishment on 16 to 17 April 1999, all patients developed symptoms of disease on 17 to 19 April and were admitted to our hospital on 19 to 22 April. Six patients were hospitalized for a median period of 3 (range, 2 to 4) days, and the others were managed as outpatients. After 14 to 16 days, the patients received a questionnaire to retrospectively determine the duration of the fever, confinement to bed, and symptoms experienced during the illness. Informed consent was obtained from all patients by using a protocol approved by the Committee on Research Ethics at the Medical Faculty, Umeå University, Umeå, Sweden.
A retrospective cohort study suggested that the whirlpool was the source of the outbreak (18). Two groups of healthy control individuals were included. For measurement of
and V
9V
2 T-cell counts, values from 12 male and 14 female adults (mean age, 39.7 years) were available at the
laboratory. These values were quite similar to those previously reported from a previous investigation of a Swedish normal adult population (10). For assay of cytokine production ex vivo,
samples from six male and four female adults (mean age, 34.3 years)
were obtained concomitantly with patient samples.
Blood chemistry. Blood neutrophil and platelet counts were determined by standard Coulter counter technique on a Sysmex SE-9000 instrument (Toa Medical Electronics Co., Kobe, Japan), and serum C-reactive protein levels were measured with a dry-chemistry enzymatic sandwich immunoassay technique on an Ectachem Instrument (Johnson & Johnson Clinical Diagnostics Inc., Rochester, N.Y.).
Microbiology.
By using heat-killed L. pneumophila
serogroups 1 to 8, L. bozemanii, L. micdadei, and
L. longbeachae serogroups 1 and 2 as antigens, an
immunofluorescent immunoglobulin G (IgG) antibody test was performed at
the Swedish Institute for Infectious Disease Control, Stockholm,
Sweden, as previously described (7). From each patient,
serum samples were obtained 2 to 4 days after onset of disease, at days
14 to 16, and at 5 to 6 weeks after onset. In the first sample, all 14 patients showed a titer of serum antibodies to all legionella antigens
of <32. In the second or third sample, all 14 patients showed a
4-fold increase in the titer of serum antibodies specific to L. micdadei, in three cases to a titer of 64, in six cases to 128, and in the remaining five cases to 256. The titers of all samples
toward the remaining 11 legionella antigens were <32 up to 6 weeks
after the onset of disease.
MAbs.
Monoclonal antibodies (MAbs) to the 
TCR (clone
WT31, fluorescein isothiocyanate [FITC] conjugated) and the 
TCR (11F2, FITC and phycoerythrin [PE] conjugated) were purchased
from Becton Dickinson, Sunnyvale, Calif. Antibodies to the 
TCR
(BMA 031, FITC conjugated) and the 
TCR (5.A6.E9, PE conjugated)
were also obtained from Serotec, Oxford, United Kingdom. From this source, CD3 (UCH-T1, PE conjugated), TCR-V
2 (7A5, FITC conjugated), and TCR-V
2 (15D, PE conjugated) antibodies were purchased as well.
Antibodies to human IFN-
(4S.B3, PE conjugated), TNF-
(MAb11, PE
conjugated), and CD94 (cloneHP-3D9, FITC conjugated) and a mouse IgG1
PE-conjugated isotype control were obtained from Pharmingen, San Diego,
Calif. Antibodies to interleukin-4 (clone 8604B312) and a mouse IgG2
isotype control came from Biosource, Fleurus, Belgium. TCR V
9 (B3,
FITC conjugated) and TCR V
2 (B6, PE conjugated) antibodies were
purchased from Pharmingen. Antibodies to CD94 (cloneHP-3D9, FITC
conjugated), reacting with the 70-kDa dimer Kp43, were also from Pharmingen.
Flow cytometry analysis of lymphocyte subsets. Surface phenotyping of cells of EDTA-treated blood was performed with conjugated MAbs. Aliquots (50 µl) of blood were incubated with 10 µl of normal mouse serum at a dilution of 1:500 (DAKO, Glostrup, Denmark) for 15 min at room temperature, and 5 µl of appropriate MAbs was added, followed by incubation for 25 min at room temperature. Two milliliters of FACS lysing solution (Becton Dickinson) containing 1% paraformaldehyde was then added to each tube. After 10 min of incubation, cells were washed twice with Cell-Wash solution (Becton Dickinson), resuspended in 500 µl of FACS-flow solution (Becton Dickinson), and stored at 4°C before analysis.
With a FACSort instrument (Becton Dickinson), 10,000 events per sample were recorded. The data were collected and analyzed by use of CellQuest software (Becton Dickinson). Lymphocytes were gated according to their morphologic parameters by means of forward scatter and side scatter analysis or by expression of CD3. Results were expressed as the percentage of CD3 cells stained by a given label.Analysis of cytokine expression by T cells.
For enumeration
of cytokine-producing cells, a 100-µl blood sample was diluted with
400 µl of RPMI 1640 medium. Cells were stimulated with 1 ng of
phorbol myristate acetate (Sigma, Madison, Wis.) per ml and 1 µM ionomycin (Sigma). Extracellular cytokine transport was blocked by
addition of 3 µM monensin (Sigma), and cells were incubated for
4 h at 37°C. This time period was found to be optimal when the
technique was standardized for demonstration of TNF-
and IFN-
expression (28). After stimulation, cells were washed once
and stained with conjugated anti-CD3 antibody and anti-TCR 
or
anti-TCR 
antibody for 15 min on ice. Erythrocytes were then
lysed by addition of 1 ml of FACS lysing solution (Becton Dickinson)
for 10 min, washed once, and fixed for 10 min with ice-cold
phosphate-buffered saline containing 4% paraformaldehyde and 0.1%
saponin (Sigma). Fixed cells were washed once in Cell-Wash solution
(Becton Dickinson) containing 0.1% saponin and stained for 15 min on
ice with anti-cytokine or isotype control PE-conjugated antibody.
Staining was followed by two washes in Cell-Wash solution-saponin and
one wash in Cell-Wash solution containing 1% bovine serum albumin.
Finally, cells were resuspended in 500 µl of FACS flow solution
(Becton Dickinson). Cytokine analysis was performed on CD3-gated cells.
Thresholds for cytokine signals were assessed after staining of samples
with irrelevant isotype-specific antibodies. Results were expressed as
the percentage of cytokine-positive cells in the respective
subpopulation. Due to saponin permeabilization, both cytoplasmic and
membrane-bound cytokines were detected.
Statistical analysis. For statistical evaluation, the Wilcoxon paired test was used.
| |
RESULTS |
|---|
|
|
|---|
Clinical data.
All patients presented with fever (maximum,
39.4 to 40.5°C; mean, 39.9°C; n = 14) and
influenza-like symptoms. Vital functions were never affected. In three
cases, auscultation disclosed discrete pulmonary rales. By radiography,
discrete pulmonary infiltrates were found in two of these patients and
in a third patient. In one further patient, a small amount of pleural
fluid occurred. At follow-up, all chest radiographs were normalized.
Macrolides were prescribed for 5 to 10 days in 12 patients, whereas two
patients received no antibiotics. The two latter patients did not
deviate from the others regarding blood chemistry or 
and
V
9V
2 T-cell values. According to the patient-completed
questionnaire, the most frequent symptoms were myalgia
(14), headache (13), arthralgia (12), dizziness (12), fatigue
(11), breathing discomfort (7), nausea,
vomiting or diarrhea (5), cough (4), and disturbance of short-term memory (3). Defervescence
occurred after a median period of 4 days (range, 2 to 7 days;
n = 14), and the patients were bedridden for a medium
of 5 days (range, 2 to 8 days).
Inflammatory parameters.
On admission to the hospital, i.e., 1 to 2 days after the onset of disease, neutrophil counts and levels of
C-reactive protein were markedly elevated, compared to normal
laboratory values of healthy adults (Fig.
1). Within a few days, both reactants
normalized and they remained normal throughout the study period.
Relative thrombocytosis was demonstrated later in the course (Fig. 1).
|
Proportions of 
TCR-expressing T cells at various intervals
after onset of disease.
From days 4 to 6 to days 14 to 16 after
onset of disease, a rise in the proportion of 
T cells was
generally observed (Fig. 2). Thereafter,
the proportion declined gradually over a 6-month-period. The magnitude
of the 
T-cell expansion varied considerably among individuals.
This variation was not the result of a day-to-day variation inherent in
the assay, because differences among individuals were retained from one
sample to another (Fig. 2). Results were similar when expressed as the
absolute numbers of 
T cells per microliter of blood (data not
shown), indicating that the percentage of 
T cells increased
because of expansion and not as a result of a concomitant decrease in
the number of 
T cells.
|
9V
2 T cells were analyzed separately, these cells were
found to account for the changes in 
T-cell percentages (Table 1). Irrespective of the interval, 
T cells other than V
9V
2 T cells remained stationary at
2% of
the total number of CD3+ cells. An unexpected
finding was a marked decrease in V
9V
2 T cells early after onset.
In the first sample, obtained 4 to 6 days after onset, the mean
percentage was as low as 1.0% ± 0.5% (Table 1) and significantly
(P < 0.001) lower than in control subjects (5.0% ± 3.9%). Thus, an initial reduction and a subsequent dramatic,
long-lasting increase in V
9V
2 T cells were observed in the
peripheral blood of legionellosis patients. At 6 months, values were
still significantly (P = 0.001) higher than those of
the control group (Table 1).
|
9V
2 T cells express the inhibitory
CD94/NKG2-A receptor for HLA class I molecules. The percentage of
CD94+ cells of V
9V
2 T cells increased
significantly (P = 0.01) from days 4 to 6 to the
interval of 5 to 7 weeks after onset and normalized at 6 months (Fig.
3).
|
Cytokine expression of 
T cells.
At intervals after the
onset of disease, cytokine expression by 
T cells in response to
short-term stimulation with phorbol myristate acetate and ionomycin was
measured in various numbers of patients. On days 14 to 16, the
proportions of cells expressing TNF-
and/or IFN-
were high (Fig.
4). At 5 to 7 weeks, a decrease in
cytokine-expressing cells occurred and at this interval, the percentage
of TNF-
-expressing cells was significantly (P = 0.02) lower than the values of control subjects. In samples obtained at
6 months, the percentages of cells expressing the cytokines were
restored (Fig. 4). Irrespective of the time of sampling, only a few
percent of the cells expressed interleukin-4 (data not shown).
|
| |
DISCUSSION |
|---|
|
|
|---|
The present outbreak was characterized by a brief incubation period (24 to 48 h) and a transient, influenza-like disease. Neutrophil counts and levels of C-reactive protein increased rapidly and were also quickly normalized. Although pulmonary changes were occasionally found by radiography, they were discrete and symptoms conformed better to Pontiac fever than to Legionnaires' disease. As in two previous outbreaks of whirlpool-associated Pontiac fever in Scotland and Denmark (17, 27), L. micdadei was implicated as the causative agent. In spite of our failure to isolate the causative agent, the consistency of the serological findings on the patient material, together with a uniform clinical expression well in accordance with Pontiac disease, makes the etiology highly likely. It should be added that the specificity of the immunofluorescence test is extremely high (39). Similar to the present experience, attempts to isolate L. micdadei from patients also failed in the two previous outbreaks (17, 27).
All of the changes in 
T cells recorded here refer to the
V
9V
2 T-cell subset and show a uniform pattern among the patients. An initial decrease was followed by a rapid and prolonged increase. In
blood samples obtained 4 to 6 days after onset of disease, the mean
percentage of V
9V
2 T cells was only 20% of the values of control
subjects. Except for this occasion, samples from all patients, as well
as control subjects, showed a predominance of V
9V
2 cells among
9V
T cells. The simplest explanation for the depletion early
after the onset of the disease would be an extravasal migration of the
cells into the site of infection, preceding an antigen-induced
expansion and reentry into the circulation. It remains to be shown
whether the cells accumulate in bronchoalveolar fluid and also whether
such an initial depletion of V
9V
2 T cells occurs in other
intracellular bacterial infections. In experimental Plasmodium
falciparum infection, two infected humans showed a transient
decrease in V
9V
2 T cells in peripheral blood during the second
week of infection (34).
The pronounced and protracted increase in V
9V
2 T cells, in both
absolute numbers and proportions of cells, was similar to that
previously recorded in patients with ulceroglandular tularemia, an
invasive febrile disease caused by another facultatively intracellular bacterium (24). Such a dramatic and long-standing
elevation of V
9V
2 T cells in two intracellular bacterial
diseases, widely differing in their clinical pictures, supports the
assumption that V
9V
2 T cells are pathophysiologically important
in this kind of infection. No clinical data are available regarding the possible relevance of the long-standing increase in V
9V
2 T cells. Increased proportions of the subset have been reported in studies of
healthy individuals living in regions with increased exposure to
intracellular pathogens (10).
The present results imply that Pontiac fever is due to infection rather than exposure to dead bacteria or bacterial toxins. Several pieces of evidence support this line. In guinea pigs, which are highly susceptible to L. pneumophila, aerogenic exposure to dead organisms of the species caused no signs of disease (1). Moreover, strains of L. pneumophila causing Pontiac fever did not differ from those causing Legionnaires' disease (12), and pneumonic and nonpneumonic forms of legionellosis have been described in patients with a common-source exposure (15). Finally, urine samples from patients with Pontiac fever have shown the presence of Legionella antigen (13).
The function of V
9V
2 T cells in host response to intracellular
infections remains elusive. In the samples obtained here 14 to 16 days
after the onset of legionellosis, a majority of the cells produced
TNF-
and IFN-
after being exposed for 4 h to phorbol
myristate acetate. One month later, the cytokine expression capability
of the V
9V
2 T cells was decreased, TNF-
expression in
particular. These data may reflect an initial cytokine response important in the activation of bactericidal macrophages, followed by
down regulation or modulation of the inflammatory response. A similar
change has been observed in tularemia (24). In vitro studies suggest that 
T cells are subjected to a fine-tuned combination of stimulation and inhibition by their interaction with
different membrane receptors (26, 31). One of the
receptors involved in down regulation is CD94, a type C lectin. In
vitro data suggest that CD94 expression is increased on V
9V
2 T
cells as a result of antigen stimulation (3). We found
that its expression increased at 5 to 7 weeks after onset of disease,
compared with 4 to 6 days after onset, i.e., concomitantly with the
decrease in cytokine expression. In fact, experimental work on
intracellular infections has suggested a dual role for 
T cells.
After contributing to an early inflammatory response by cytokine
expression and activation of macrophages, 
T cells are suggested
to participate in termination of the immune response (4).
In conclusion, patients with Pontiac fever-like disease showed an early
depletion of V
9V
2 T cells from the circulation, followed by a
dramatic increase and a subsequent slow decline over the next 6 months.
The capability of the cells to express IFN-
and TNF-
seemed to be
down-regulated after the acute phase of the disease. These results
support the assumption that V
9V
2 T cells are pathophysiologically
important in intracellular bacterial infections, including a mild and
transient condition such as Pontiac fever.
| |
ACKNOWLEDGMENTS |
|---|
Financial support for this study was received from the Swedish Medical Research Council (no. 9485), Västerbottens läns landsting, and the Medical Faculty, Umeå University, Umeå, Sweden.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Department of Infectious Diseases, Umeå University, Umeå University Hospital, SE-901 85 Umeå, Sweden. Phone: 46-90-7852300. Fax: 46-90-133006. E-mail: arne.tarnvik{at}infdis.umu.se.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Berendt, R. F., H. W. Young, R. G. Allen, and G. L. Knutsen. 1980. Dose-response of guinea pigs experimentally infected with aerosols of Legionella pneumophila. J. Infect. Dis. 141:186-192[Medline]. |
| 2. |
Bertotto, A.,
R. Gerli,
F. Spinozzi,
C. Muscat,
F. Scalise,
G. Castellucci,
M. Sposito,
F. Candio, and R. Vaccaro.
1993.
Lymphocytes bearing the ![]() T cell receptor in acute Brucella melitensis infection.
Eur. J. Immunol.
23:1177-1180[Medline].
|
| 3. |
Boullier, S.,
Y. Poquet,
F. Halary,
M. Bonneville,
J.-J. Fournie, and M.-L. Gougeon.
1998.
Phosphoantigen activation induces surface translocation of intracellular CD94/NKG2A class I receptor on CD94 peripheral V 9 V 2 T cells but not on CD94 thymic or mature ![]() T cell clones.
Eur. J. Immunol.
28:3399-3410[CrossRef][Medline].
|
| 4. |
Carding, S. R., and P. J. Egan.
2000.
The importance of ![]() T cells in the resolution of pathogen-induced inflammatory immune responses.
Immunol. Rev.
173:98-108[CrossRef][Medline].
|
| 5. |
Constant, P.,
F. Davodeau,
M. A. Peyrat,
Y. Poquet,
G. Puzo,
M. Bonneville, and J.-J. Fournie.
1994.
Stimulation of human gamma delta T cells by nonpeptidic mycobacterial ligands.
Science
264:267-270 |
| 6. |
De Libero, G.
1997.
Sentinel function of broadly reactive human ![]() T cells.
Immunol. Today
18:22-26[Medline].
|
| 6a. | Edelstein, P. H. 1985. Legionella, p. 373-381. In E. H. Lenette, A. Balows, W. J. Hausler, Jr., and H. J. Shadomy (ed.), Manual of clinical microbiology, 4th ed. American Society for Microbiology, Washington, D.C. |
| 7. | Edelstein, P. H. 1992. Detection of antibodies to Legionella., p. 459-466. In N. R. Rose, E. C. de Macario, J. L. Fahey, H. Friedman, and G. M. Penn (ed.), Manual of clinical laboratory immunology, 4th ed. American Society for Microbiology, Washington, D.C. |
| 8. | Edelstein, P. H. 1993. Legionnaires' disease. Clin. Infect. Dis. 16:741-747[Medline]. |
| 9. | England, A. C., III, D. W. Fraser, B. D. Plikaytis, T. F. Tsai, G. Storch, and C. V. Broome. 1981. Sporadic legionellosis in the United States: the first thousand cases. Ann. Intern. Med. 94:164-170. |
| 10. |
Esin, S.,
M. Shigematsu,
S. Nagai,
A. Eklund,
H. Wigzell, and J. Grunewald.
1996.
Different percentages of peripheral blood ![]() + T cells in healthy individuals from different areas of the world.
Scand. J. Immunol.
43:593-596[CrossRef][Medline].
|
| 11. |
Follows, G. A.,
M. E. Munk,
A. J. Gatrill,
P. Conradt, and S. H. E Kaufmann.
1992.
Gamma interferon and interleukin 2, but not interleukin 4, are detectable in / T-cell cultures after activation with bacteria.
Infect. Immun.
60:1229-1231 |
| 12. |
Fraser, D. W.,
D. C. Deubner,
D. L. Hill, and D. K. Gilliam.
1979.
Nonpneumonic, short-incubation-period legionellosis (Pontiac fever) in men who cleaned a steam turbine condenser.
Science
205:690-691 |
| 13. |
Friedman, S.,
K. Spitalny,
J. Barbaree,
Y. Faur, and R. McKinney.
1987.
Pontiac fever outbreak associated with a cooling tower.
Am. J. Public Health
77:568-572 |
| 14. |
García, V. E.,
P. A. Sieling,
J. H. Gong,
P. F. Barnes,
K. Uyemura,
Y. Tanaka,
B. R. Bloom,
C. T. Morita, and R. L. Modlin.
1997.
Single-cell analysis of ![]() T cell responses to nonpeptide mycobacterial antigens.
J. Immunol.
159:1328-1335[Abstract].
|
| 15. | Girod, J. C., R. C. Reichman, W. C. Winn, Jr., D. N. Klaucke, R. L. Vogt, and R. Dolin. 1982. Pneumonic and nonpneumonic forms of legionellosis. The result of a common-source exposure to Legionella pneumophila. Arch. Intern. Med. 142:545-547[Abstract]. |
| 16. |
Glick, T. H.,
M. B. Gregg,
B. Berman,
G. Mallison,
W. W. Rhodes, Jr., and I. Kassanoff.
1978.
Pontiac fever: an epidemic of unknown etiology in a health department. I. Clinical and epidemiologic aspects.
Am. J. Epidemiol.
107:149-160 |
| 17. | Goldberg, D. J., J. G. Wrench, P. W. Collier, J. A. Emslie, R. J. Fallon, G. I. Forbes, T. M. McKay, A. C. Macpherson, T. A. Markwick, and D. Reid. 1989. Lochgoilhead fever: outbreak of non-pneumonic legionellosis due to Legionella micdadei. Lancet i:316-318[CrossRef]. |
| 18. | Götz, H. M., A. Tegnell, B. De Jong, K. A. Broholm, M. Kuusi, I. Kallings, and K. Ekdahl. 2001. A whirlpool associated outbreak of Pontiac fever at a hotel in Northern Sweden. Epidemiol. Infect. 126:241-247[CrossRef][Medline]. |
| 19. |
Ho, M.,
H. K. Webster,
P. Tongtawe,
K. Pattanapanyasat, and W. P. Weidanz.
1990.
Increased ![]() T cells in acute Plasmodium falciparum malaria.
Immunol. Lett.
25:139-141[CrossRef][Medline].
|
| 20. | Horwitz, M. A. 1983. Cell-mediated immunity in Legionnaires' disease. J. Clin. Investig. 71:1686-1697. |
| 21. |
Ito, M.,
N. Kojiro,
T. Ikeda,
T. Ito,
J. Funada, and T. Kokubu.
1992.
Increased proportions of peripheral blood ![]() T cells in patients with pulmonary tuberculosis.
Chest
102:195-197 |
| 22. |
Jouen-Beades, F.,
E. Paris,
C. Dieulois,
J.-F. Lemeland,
V. Barre-Dezelus,
S. Marret,
G. Humbert,
J. Leroy, and F. Tron.
1997.
In vivo and in vitro activation and expansion of ![]() T cells during Listeria monocytogenes infection in humans.
Infect. Immun.
65:4267-4272[Abstract].
|
| 23. |
Kaufmann, A. F.,
J. E. McDade,
C. M. Patton,
J. V. Bennett,
P. Skaliy,
J. C. Feeley,
D. C. Anderson,
M. E. Potter,
V. F. Newhouse,
M. B. Gregg, and P. S. Brachman.
1981.
Pontiac fever: isolation of the etiologic agent (Legionella pneumophila) and demonstration of its mode of transmission.
Am. J. Epidemiol.
114:337-347 |
| 24. |
Kroca, M.,
A. Tärnvik, and A. Sjöstedt.
2000.
The proportion of ![]() T cells increases after the first week of onset of tularaemia and remains elevated for more than a year.
Clin. Exp. Immunol.
120:280-284[CrossRef][Medline].
|
| 25. |
Lang, F.,
M. A. Peyrat,
P. Constant,
F. Davodeau,
J. David-Amelie,
Y. Poquet,
H. Vié,
J. J. Fournié, and M. Bonneville.
1995.
Early activation of human V 9V 2 T cell broad cytotoxicity and TNF production by nonpeptidic mycobacterial ligands.
J. Immunol.
154:5986-5994[Abstract].
|
| 26. | Lopez-Botet, M., J. J. Perez-Villar, M. Carretero, A. Rodriguez, I. Melero, T. Bellon, M. Llano, and F. Navarro. 1997. Structure and function of the CD94 C-type lectin receptor complex involved in recognition of HLA class I molecules. Immunol. Rev. 155:165-174[CrossRef][Medline]. |
| 27. | Lüttichau, H. R., C. Vinther, S. A. Uldum, J. Møller, M. Faber, and J. S. Jensen. 1998. An outbreak of Pontiac fever among children following use of a whirlpool. Clin. Infect. Dis. 26:1374-1378[Medline]. |
| 28. | Mascher, B., P. Schlenke, and M. Seyfarth. 1999. Expression and kinetics of cytokines determined by intracellular staining using flow cytometry. J. Immunol. Methods 223:115-121[CrossRef][Medline]. |
| 29. | Miller, L. A., J. L. Beebe, J. C. Butler, W. Martin, R. Benson, R. E. Hoffman, and B. S. Fields. 1993. Use of polymerase chain reaction in an epidemiologic investigation of Pontiac fever. J. Infect. Dis. 168:769-772[Medline]. |
| 30. |
Pfeffer, K.,
B. Schoel,
H. Gulle,
S. H. E. Kaufmann, and H. Wagner.
1990.
Primary responses of human T cells to mycobacteria: a frequent set of / T cells are stimulated by protease-resistant ligands.
Eur. J. Immunol.
20:1175-1179[Medline].
|
| 31. |
Poccia, F.,
B. Cipriani,
S. Vendetti,
V. Colizzi,
Y. Poquet,
L. Battistini,
M. López-Botet,
J.-J. Fournié, and M.-L. Gougeon.
1997.
CD94/NKG2 inhibitory receptor complex modulates both anti-viral and anti-tumoral responses of polyclonal phosphoantigen-reactive V 9V 2 T lymphocytes.
J. Immunol.
159:6009-6017[Abstract].
|
| 32. |
Poquet, Y.,
M. Kroca,
F. Halary,
S. Stenmark,
M.-A. Peyrat,
M. Bonneville,
J.-J. Fournie, and A. Sjöstedt.
1998.
Expansion of V 9V 2 T cells is triggered by Francisella tularensis-derived phosphoantigens in tularemia but not after tularemia vaccination.
Infect. Immun.
66:2107-2114 |
| 33. |
Raziuddin, S.,
A. W. Telmasani,
M. El-Hag El-Awad,
O. Al-Amari, and M. Al-Janadi.
1992.
![]() T cells and the immune response in visceral leishmaniasis.
Eur. J. Immunol.
22:1143-1148[Medline].
|
| 34. |
Rzepczyk, C. M.,
S. Stamatiou,
K. Anderson,
A. Stowers,
Q. Cheng,
A. Saul,
A. Allworth,
J. McCormack,
M. Whitby,
C. Olive, and G. Lawrence.
1996.
Experimental human Plasmodium falciparum infections: longitudinal analysis of lymphocyte responses with particular reference to ![]() T cells.
Scand. J. Immunol.
43:219-227[CrossRef][Medline].
|
| 35. |
Scalise, F.,
R. Gerli,
G. Castellucci,
F. Spinozzi,
G. M. Fabietti,
S. Crupi,
L. Sensi,
R. Britta,
R. Vaccaro, and A. Bertotto.
1992.
Lymphocytes bearing the ![]() T-cell receptor in acute toxoplasmosis.
Immunology
76:668-670[Medline].
|
| 36. |
Schneider, T.,
H.-U. Jahn,
O. Liesenfeld,
D. Steinhoff,
E.-O. Riecken,
M. Zeitz, and R. Ullrich.
1997.
The number and proportion of V 9V 2 T cells rise significantly in the peripheral blood of patients after the onset of acute Coxiella burnetii infection.
Clin. Infect. Dis.
24:261-264[Medline].
|
| 37. |
Sumida, T.,
T. Maeda,
H. Takahashi,
S. Yoshida,
F. Yonaha,
A. Sakamoto,
H. Tomioka,
T. Koike, and S. Yoshida.
1992.
Predominant expansion of V 9/V 2 T cells in a tularemia patient.
Infect. Immun.
60:2554-2558 |
| 38. |
Tanaka, Y.,
S. Sano,
E. Nieves,
G. De Libero,
D. Rosa,
R. L. Modlin,
M. B. Brenner,
B. R. Bloom, and C. T. Morita.
1994.
Nonpeptide ligands for human ![]() T cells.
Proc. Natl. Acad. Sci. USA
91:8175-8179 |
| 39. |
Winn, W. C., Jr.
1988.
Legionnaires disease: historical perspective.
Clin. Microbiol. Rev.
1:60-81 |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. | Infect. Immun. |
|---|---|---|
| J. Clin. Microbiol. | J. Virol. | ALL ASM JOURNALS |